The search for new anticancer drugs has increased in the last decades since currently used chemotherapeutic drugs show many adverse effects. Previous studies show that kinase inhibitors exhibit antitumor activity [1,2]. According to studies, protein kinase dysfunctions have been associated with the development of various types and subtypes of human cancers [1]. Over 25 kinase inhibitors are approved as anticancer drugs [3]. One of them is sunitinib, which is used to treat kidney cancer and gastrointestinal stromal tumors [4]. A common feature of most tumors is a low level of oxygen, called hypoxia. This hypoxic stress creates an adaptive mechanism on cancer cells survival, proliferation, and plays a vital role in migration and invasiveness in cancer cells [5], thus there is a need to study compounds activity in hypoxia conditions.
The aim of our study was to evaluate the effect of new sunitinib analogues on migration of triple negative breast cancer cell line MDA-MB-231 in normoxia and hypoxia.
Materials and methods. Experiments were performed on human cancer cell line MDA-MB-231. Kinase inhibitors, which are sunitinib analogues, have been synthesized at the University of Cagliari, Italy, and their synthesis and characterization was published [6]. Compound effect on breast cancer cell ability to migrate was examined using single cell tracking assay. This experiment was performed on a special imaging dish with a grid. Cells were seeded at a low concentration, to get 50-70 cells in total on a grid area. Cells were allowed to attach overnight, and then the compound solutions were added. Images of the migrating cells were taken at one-hour intervals for 8 hours by using an inverted microscope. Single cells were tracked and the cell migration distance was measured by ImageJ software. Then the average cell migration velocity was calculated. Also, wound healing assay was used to evaluate compound effect on cell migration. The wound was created in a cell monolayer. Images were taken at the beginning and at regular 24 hours intervals. All compounds were used at 50% of their established EC50 values. Hypoxia was induced using cobalt chloride.
Results. Single cell experiment results showed that in normoxia conditions kinase inhibitors 1,6 and 8 reduced cell migration compared to the control. In hypoxia, only compound 6 inhibited breast cancer cells migration. However, sunitinib was from 1,4 to 2,5 times more active compared to analogues. Wound healing assay results showed that compounds 1,6 and 17 had the greatest effect on the migration of the MDA-MB-231 cell line. In hypoxia, compounds inhibitory effect was statistically significantly stronger.
Conclusions. Tested kinase inhibitors possess anticancer activity on triple-negative breast cancer cell line. They inhibit migration of cells, and may be worthy for further studies.